WORST PROGNOSIS OF HYPOVASCULAR HEPATOCELLULAR CARCINOMA (HCC)

被引：3
|
作者：
Mayer, J. [1 ]
Auriol, J. [1 ]
Muscari, F. [2 ]
Carrere, N. [2 ]
Bournet, B. [3 ]
Bureau, C. [4 ]
Vinel, J. -P. [4 ]
Otal, P. [1 ]
Peron, J. -M. [4 ]
机构：
[1] Hop Rangueil, Serv Radiol, Toulouse, France
[2] Hop Rangueil, Serv Chirurg Digest, Toulouse, France
[3] Hop Rangueil, Serv Gastroenterol & Hepatol, Toulouse, France
[4] Hop Purpan, Serv Hepatogastroenterol, Toulouse, France
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60574-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [11] Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
    Schuette, Kerstin
    Schulz, Christian
    Poranzke, Janine
    Antweiler, Kai
    Bornschein, Jan
    Bretschneider, Tina
    Arend, Joerg
    Ricke, Jens
    Malfertheiner, Peter
    BMC GASTROENTEROLOGY, 2014, 14
  • [12] Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
    Kerstin Schütte
    Christian Schulz
    Janine Poranzke
    Kai Antweiler
    Jan Bornschein
    Tina Bretschneider
    Jörg Arend
    Jens Ricke
    Peter Malfertheiner
    BMC Gastroenterology, 14
  • [13] No Need of Immediate Treatment for Hypovascular Tumors Associated with Hepatocellular Carcinoma
    Yutaka Midorikawa
    Tadatoshi Takayama
    Satoshi Nara
    Takuya Hashimoto
    Kiyohiko Omichi
    Kiyoko Ebisawa
    Tokio Higaki
    Shingo Tsuji
    Hirohiko Sakamoto
    Kazuaki Shimada
    Masatoshi Makuuchi
    World Journal of Surgery, 2016, 40 : 2460 - 2465
  • [14] Hepatocellular carcinoma (HCC): An update
    Rougier, Philippe
    Mitry, Emmanuel
    Barbare, Jean-Claude
    Taieb, Julien
    SEMINARS IN ONCOLOGY, 2007, 34 (02) : S12 - S20
  • [15] Management of hepatocellular carcinoma (HCC)
    Milgrom D.P.
    Maluccio M.A.
    Koniaris L.G.
    Current Surgery Reports, 4 (6)
  • [16] Human Hepatocellular Carcinoma (HCC)
    Buonaguro, Luigi
    CANCERS, 2020, 12 (12)
  • [17] IMMUNOTHERAPY OF HEPATOCELLULAR CARCINOMA (HCC)
    Shimoda, Masafumi
    Carlson, Rolf I.
    Wands, Jack R.
    HEPATOLOGY, 2010, 52 (04) : 948A - 948A
  • [18] Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients
    Yang, Haiyun
    Xu, Ming
    Chi, Xiufang
    Yan, Qun
    Wang, Yadong
    Xu, Wen
    Zhuang, Kangmin
    Li, Aimin
    Liu, Side
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (05) : 554 - 563
  • [19] No Need of Immediate Treatment for Hypovascular Tumors Associated with Hepatocellular Carcinoma
    Midorikawa, Yutaka
    Takayama, Tadatoshi
    Nara, Satoshi
    Hashimoto, Takuya
    Omichi, Kiyohiko
    Ebisawa, Kiyoko
    Higaki, Tokio
    Tsuji, Shingo
    Sakamoto, Hirohiko
    Shimada, Kazuaki
    Makuuchi, Masatoshi
    WORLD JOURNAL OF SURGERY, 2016, 40 (10) : 2460 - 2465
  • [20] Prognosis and Therapy for Ruptured Hepatocellular Carcinoma (HCC): Should Naive HCC Rupture Be Included in T4?
    Kawamura, Tomoe
    Shiraishi, Akiko
    Hiraoka, Atsushi
    Kawasaki, Hideki
    Hirooka, Masashi
    Matsuura, Bunzo
    Hiasa, Yoichi
    Michitaka, Kojiro
    GASTROENTEROLOGY, 2014, 146 (05) : S478 - S478
12345